You are here

clinical trials

Novartis plots to retain hives patients with monoclonal antibody that outshines Xolair

Novartis plots to retain hives patients with monoclonal antibody that outshines Xolair

Endpoints

monoclonal antibodies

clinical trials

Flag link:

Biohaven's orally dissolving tablet meets in Phase III for acute migraine

Biohaven's orally dissolving tablet meets in Phase III for acute migraine

BioCentury

clinical trials

Flag link:

Aprea heading for Phase III with €50M series C round

Aprea heading for Phase III with €50M series C round

BioCentury

clinical trials

Flag link:

Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial

Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial

Fierce Biotech

brexpiprazole-sertraline

clinical trials

Flag link:

Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial

Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial

BioSpace

clinical trials

Flag link:

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

Xconomy

clinical trials

Flag link:

When Clinical Trials Are Marketing Ploys, Not Science

When Clinical Trials Are Marketing Ploys, Not Science

Forbes

clinical trials

Flag link:

Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3

Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3

Fierce Biotech

clinical trials

metastatic prostate cancer

Flag link:

FDA Warns Investigator for Violating Clinical Hold

FDA Warns Investigator for Violating Clinical Hold

RAPS.org

clinical trials

Flag link:

Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It?

Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It?

Motley Fool

clinical trials

Dravet syndrome

Flag link:

Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

Stat

Vertex Pharmaceuticals

cystic fibrosis

clinical trials

VX-659 + tezacaftor + ivacaftor

Flag link:

FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns

FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns

BioSpace

clinical trials

type 2 diabetes

Flag link:

After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS

After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS

Xconomy

Edge Therapeutics

clinical trials

PDS Biotechnology

immuno-oncology

Flag link:

Novo Nordisk’s diabetes pill clears cardiac safety hurdle

Novo Nordisk’s diabetes pill clears cardiac safety hurdle

Pharmaforum

type 2 diabetes

clinical trials

cardiovascular outcomes

Flag link:

FDA's Woodcock: 'The clinical trial system is broken'

FDA's Woodcock: 'The clinical trial system is broken'

Biopharma Dive

clinical trials

Flag link:

Stallergenes' allergy immunotherapy hits goal in phase 3

Stallergenes' allergy immunotherapy hits goal in phase 3

Fierce Biotech

Stallergenes Greer

dust mite allergy

clinical trials

Flag link:

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Marketwatch

clinical trials

Flag link:

Blueprint posts 'impressive' data for lead candidate, but investor response tepid

Blueprint posts 'impressive' data for lead candidate, but investor response tepid

Biopharma Dive

Blueprint Medicines

clinical trials

gastrointestinal cancer

Flag link:

AstraZeneca’s Mystic OS analysis paints tremelimumab as a dud in NSCLC

AstraZeneca’s Mystic OS analysis paints tremelimumab as a dud in NSCLC

Fierce Biotech

clinical trials

non-small cell lung cancer

Flag link:

TrialScope Unites Industry Leaders to Address Key Issues of Clinical Trial Disclosure and Transparency at 2018 Strategic Partner Meeting

clinical trials

Flag link:

Pages